Seems the team at IMU think a little bit more of the ODD than our friends from RAC
"Receiving Orphan Drug Designation from the FDA is a major milestone for us. It reflects the potential of #VAXINIA to address the urgent need for new treatments for cholangiocarcinoma, a disease with limited therapeutic options. We are excited to continue advancing this program, which has already shown meaningful clinical responses in patients," MD and CEO Leslie Chong said. $IMU
Read more: https://thewest.com.au/business/bulls-n-bears/imugene-gets-crucial-fda-nod-for-bile-tract-cancer-drug-c-16099489?utm_source=sfmc&utm_medium=email&utm_campaign=TheWest+-+Business&utm_id=87175&sfmc_id=17513396…
https://x.com/TeamImugene/status/1836562776422224371
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 5795292 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3258567 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |